Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Drotaverine Hydrochloride Injection

Approval Number

国药准字H20254030

Company湖南慧泽生物医药科技有限公司

Registration Date

April 30, 2025

Drug Information

Generic Name

盐酸屈他维林注射液

Dosage Form

注射剂

Strength

2ml∶40mg（按C₂₄H₃₁NO₄·HCl计）

Drug Type

化学药品

Registration Date

April 30, 2025

Company Information

Applicant Company

Company Name湖南慧泽生物医药科技有限公司

Company Address

长沙高新开发区旺龙路136号万为科技产业园3栋501

Manufacturing Company

Company Name康普药业股份有限公司

Company Address

湖南省汉寿太子庙工业园康普大道8号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy